Lantheus Holdings, Inc. Logo

Lantheus Holdings, Inc.

Develops radiopharmaceutical diagnostics and therapies to help clinicians fight disease.

LNTH | US

Overview

Corporate Details

ISIN(s):
US5165441032
LEI:
Country:
United States of America
Address:
331 TREBLE COVE ROAD, 1862 NORTH BILLERICA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Lantheus Holdings, Inc. is a leading radiopharmaceutical-focused company specializing in the development, manufacturing, and commercialization of innovative diagnostic and therapeutic products. For over 65 years, the company has pioneered next-generation solutions that assist clinicians in the diagnosis and treatment of diseases. Its portfolio includes precision diagnostics, radiotherapeutics, and artificial intelligence solutions designed to help healthcare professionals 'Find, Fight, and Follow' disease, aiming to improve patient outcomes through advanced medical imaging and targeted therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Lantheus Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Lantheus Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Lantheus Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PharmaResearch Co., Ltd. Logo
Develops regenerative medicine, devices & cosmetics using marine biotechnology.
South Korea
214450
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany
PSG
Pharmena S.A. Logo
Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.
Poland
PHR
Bulgaria
PHRM
Pharmicell Co.,Ltd. Logo
Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.
South Korea
005690
Pharming Group N.V. Logo
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
Netherlands
PHARM
Pharming Group N.V. Logo
Develops and commercializes innovative protein therapies for rare, life-threatening diseases.
United States of America
PHAR
Pharmocann Global Ltd. Logo
Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.
Israel
PMCN-M
Pharvaris N.V. Logo
Developing oral therapies for rare angioedema to treat and prevent attacks.
United States of America
PHVS
Phathom Pharmaceuticals, Inc. Logo
Develops and commercializes treatments for acid-related gastrointestinal diseases.
United States of America
PHAT

Talk to a Data Expert

Have a question? We'll get back to you promptly.